Chemo delivered into lung tumors using a catheter
Treatments studied
Part of Cancer, Digestive system, Lungs & breathing clinical trials.
This trial studies a treatment that delivers chemotherapy directly to lung tumors by placing a catheter into lung blood vessels. It may help people with lung cancer or lung metastases that are growing despite standard treatment, or who cannot tolerate it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have lung cancer or lung metastases that are mainly in the chest and are growing despite standard treatment, or you cannot tolerate standard treatment
- Your tumors cannot be removed with surgery, treated with heat/ablation, or treated with one-time focused radiation aimed at the tumor
- Your breathing and lung function are adequate (oxygen level on room air is at least 92%, and FEV1 is at least 60%)
- There is measurable tumor that can be followed on scans (for example, not only tiny nodules under 1 cm)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding an immunotherapy medicine to standard chemotherapy after surgery can improve outcomes for some people with non-small cell lung cancer. It may help by boosting the immune system to reduce the chance the cancer comes back.
This trial tests a treatment called bronchial artery chemoembolization (BACE) combined with drug therapy for advanced non-small cell lung cancer. BACE delivers chemotherapy directly to the tumor through the blood vessel that feeds it, which may help control the cancer when standard treatments have stopped working.
This trial tests whether adding a procedure called bronchial artery chemoembolization (delivering chemotherapy directly to the tumor's blood supply) to your usual care can help control lung cancer that has stabilized after first-line chemotherapy and immunotherapy. The goal is to see if it improves outcomes.
This trial is for people with advanced non-small cell lung cancer whose tumors responded well to initial chemo-immunotherapy. Instead of giving full chest radiation, doctors will only target the main tumor to see if it can prevent regrowth with fewer side effects.
This trial tests giving chemotherapy directly into the artery that feeds the tumor, which may help control advanced colorectal cancer that cannot be removed with surgery. It is for people who have not yet had other treatments and whose main tumor is in the colon or rectum.
This trial tests a new way of giving radiation (in high and low doses) together with chemotherapy and immunotherapy to treat advanced non-small cell lung cancer. The goal is to see if this combination can shrink tumors and help patients live longer.
Hear when a new Colon Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.